NAMS
NewAmsterdam Pharma Company N.VHealthcare$32.99
▼ Bearish
Mkt Cap: $3.79B|Float: 71.5M|SI: 10.6%|DTC: 8.3
Data as of market close Apr 2, 2026
IV Rank
77
IV Pctl
56%
HV 20d
52.0%
52W Range
$14-$42
ATR(14)
$1.77
Exp. Move
±13.8%
P/C Ratio
1.07
Earnings
May 7
GEX Negative
DEX Long
Net Put Premium
IV High
Max Pain Below
Exp. Move Wide
NAMS Key Options Data
- IV Rank
- 76.6%
- Total GEX
- $-0.00B
- Total DEX
- $0.4M
- Max Pain
- $30.00
- Expected Move
- ±13.8%
- Put/Call OI
- 1.07
- Net Premium
- $-0.2M
- Spot Price
- $32.99
Gamma Exposure (GEX)
Delta Exposure (DEX)
Expected Move by Expiration
| Expiration | DTE | Expected Move | Move % | Lower | Upper |
|---|---|---|---|---|---|
| 2026-04-17 | 15 | ±$4.55 | ±13.8% | $28.44 | $37.54 |
| 2026-05-15 | 43 | ±$7.43 | ±22.5% | $25.57 | $40.42 |
| 2026-06-18 | 77 | ±$3.30 | ±10.0% | $29.69 | $36.29 |
| 2026-07-17 | 106 | ±$6.25 | ±18.9% | $26.74 | $39.24 |
| 2026-08-21 | 141 | ±$11.95 | ±36.2% | $21.04 | $44.94 |
| 2026-12-18 | 260 | ±$7.75 | ±23.5% | $25.24 | $40.74 |
Explore NAMS options data including implied volatility rankings, gamma and delta exposure, max pain levels, and expected price moves. AI-generated reports provide directional, income, and earnings analysis.